Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Spectral Precise Image Study for Brain Tumors

NCT: NCT07620470 · RECRUITING

NCT IDNCT07620470
StatusRECRUITING
Start Date2025-11-28
Completion2026-12-31
SponsorPhilips Clinical & Medical Affairs Global (INDUSTRY)
First posted
Last updated

Brief Summary

The goal of this observational study is to explore the image quality of spectral CT deep learning reconstruction technology (Spectral Precise Image) of patients with confirmed brain tumors. The main question it aims to answer is: The Image Quality (IQ) and diagnostic confidence of Spectral Precise Image reconstructions

Frequently Asked Questions

What is Spectral Precise Image Study for Brain Tumors?

Spectral Precise Image Study for Brain Tumors is a clinical trial registered under NCT07620470. Current status: RECRUITING.

What is the status of NCT07620470?

The current status of NCT07620470 (Spectral Precise Image Study for Brain Tumors) is: RECRUITING.

When did Spectral Precise Image Study for Brain Tumors start?

Spectral Precise Image Study for Brain Tumors started on 2025-11-28.

Related Devices

K201745Deep Learning Image Reconstruction for Gemstone Spectral ImagingGe Medical Systems, LLC K183202Deep Learning Image ReconstructionGe Medical Systems, LLC K193170Deep Learning Image ReconstructionGe Healthcare Japan Corporation K212067Deep Learning Image ReconstructionGe Healthcare Japan Corporation K213999Deep Learning Image ReconstructionGe Medical Systems, LLC

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑